Literature DB >> 25273030

A novel approach in distinguishing between role of hydrodynamics and mechanical stresses similar to contraction forces of GI tract on drug release from modified release dosage forms.

Majde Takieddin1, Reza Fassihi.   

Abstract

The objective of this study was to determine the influence of mechanical stresses simulating gastrointestinal contraction forces of 2.0 N (stomach) and 1.2 N (intestine) on the gel properties and drug release characteristics from sustained release swelling and eroding hydrophilic matrices during dissolution studies. Two batches of tetracycline-sustained release tablets containing hydroxypropyl methyl cellulose (HPMC) were manufactured and subjected to USP apparatus II (pH 2.2 buffer) dissolution studies. Hydrated tablets were periodically removed, placed in a petri dish, and multiple times (six cycle) compressed with a flat-ended probe (diameter 1.3 cm) on a texture analyzer at preprogrammed force of either 2.0 or 1.2 N to determine force-distance profiles and changes in drug release rate. The calculated similarity factor values showed dissimilar dissolution profiles using standard dissolution profile as a reference. The similarity factor (f2) values were especially lower than 50 at 2.0 N and, when profiles between the two batches compressed at 1.2 and 2.0 N, were compared with each other. The changes in dissolution pattern and release rate were significantly different after 4 h of dissolution. At 8 h, tablets were fully hydrated and no force could be detected by the probe, indicating a very soft gel matrix. It appears that the contraction forces in the stomach and intestine are capable of altering drug release from modified release hydrophilic matrices during transit in the human GI tract. Accounting for these forces during dissolution can enhance predictions of in vivo drug release, achieve better in vitro and in vivo correlation, introduce improvement in dissolution methods, and better understand the critical quality attributes (CQAs) and factors in quality by design (QbD) during the product development process.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 25273030      PMCID: PMC4370966          DOI: 10.1208/s12249-014-0225-5

Source DB:  PubMed          Journal:  AAPS PharmSciTech        ISSN: 1530-9932            Impact factor:   3.246


  15 in total

Review 1.  The role of gamma-scintigraphy in oral drug delivery.

Authors:  I R Wilding; A J Coupe; S S Davis
Journal:  Adv Drug Deliv Rev       Date:  2001-03-01       Impact factor: 15.470

2.  Evaluation of floating and sticking extended release delivery systems: an unconventional dissolution test.

Authors:  T Dürig; R Fassihi
Journal:  J Control Release       Date:  2000-06-15       Impact factor: 9.776

3.  Applications of physiologically based absorption models in drug discovery and development.

Authors:  Neil Parrott; Thierry Lave
Journal:  Mol Pharm       Date:  2008-06-12       Impact factor: 4.939

4.  In vitro dissolution profile comparison--statistics and analysis of the similarity factor, f2.

Authors:  V P Shah; Y Tsong; P Sathe; J P Liu
Journal:  Pharm Res       Date:  1998-06       Impact factor: 4.200

5.  Determination of continuous changes in the gel layer thickness of poly(ethylene oxide) and HPMC tablets undergoing hydration: a texture analysis study.

Authors:  L Yang; B Johnson; R Fassihi
Journal:  Pharm Res       Date:  1998-12       Impact factor: 4.200

6.  The bioavailability of diclofenac from enteric coated products in healthy volunteers with normal and artificially decreased gastric acidity.

Authors:  M E Van Gelderen; M Olling; D M Barends; J Meulenbelt; P Salomons; A G Rauws
Journal:  Biopharm Drug Dispos       Date:  1994-12       Impact factor: 1.627

7.  Comparison of the mechanical destructive force in the small intestine of dog and human.

Authors:  Masaharu Kamba; Yasuo Seta; Akira Kusai; Kenji Nishimura
Journal:  Int J Pharm       Date:  2002-04-26       Impact factor: 5.875

8.  A theoretical basis for a biopharmaceutic drug classification: the correlation of in vitro drug product dissolution and in vivo bioavailability.

Authors:  G L Amidon; H Lennernäs; V P Shah; J R Crison
Journal:  Pharm Res       Date:  1995-03       Impact factor: 4.200

9.  Development of a controlled release low dose class II drug-Glipizide.

Authors:  Shahla Jamzad; Reza Fassihi
Journal:  Int J Pharm       Date:  2006-02-14       Impact factor: 5.875

10.  Distinguishing between the permeability relationships with absorption and metabolism to improve BCS and BDDCS predictions in early drug discovery.

Authors:  Caroline A Larregieu; Leslie Z Benet
Journal:  Mol Pharm       Date:  2014-03-28       Impact factor: 4.939

View more
  2 in total

1.  Magnetic Resonance Methods as a Prognostic Tool for the Biorelevant Behavior of Xanthan Tablets.

Authors:  Urša Mikac; Julijana Kristl
Journal:  Molecules       Date:  2020-12-11       Impact factor: 4.411

2.  IVIVC for Extended Release Hydrophilic Matrix Tablets in Consideration of Biorelevant Mechanical Stress.

Authors:  Valentyn Mohylyuk; Seyedreza Goldoozian; Gavin P Andrews; Andriy Dashevskiy
Journal:  Pharm Res       Date:  2020-10-22       Impact factor: 4.200

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.